CINECA IRIS Institutional Research Information System

TESTAI, LARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.172
AS - Asia 7.084
EU - Europa 6.250
SA - Sud America 998
Continente sconosciuto - Info sul continente non disponibili 610
AF - Africa 321
OC - Oceania 19
Totale 30.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.744
IT - Italia 2.511
SG - Singapore 2.254
CN - Cina 2.043
HK - Hong Kong 992
BR - Brasile 821
SE - Svezia 794
VN - Vietnam 705
DE - Germania 659
BG - Bulgaria 441
FR - Francia 356
GB - Regno Unito 336
CA - Canada 327
FI - Finlandia 278
TR - Turchia 254
RU - Federazione Russa 212
IN - India 161
KR - Corea 154
AT - Austria 144
UA - Ucraina 142
JP - Giappone 136
CI - Costa d'Avorio 127
PL - Polonia 82
NL - Olanda 65
BD - Bangladesh 64
CH - Svizzera 62
IQ - Iraq 52
AR - Argentina 47
SN - Senegal 47
MX - Messico 44
ZA - Sudafrica 43
PK - Pakistan 38
BE - Belgio 30
ID - Indonesia 30
SA - Arabia Saudita 29
VE - Venezuela 26
EC - Ecuador 25
ES - Italia 23
UZ - Uzbekistan 23
CO - Colombia 21
MA - Marocco 20
NG - Nigeria 19
AU - Australia 16
PH - Filippine 16
IR - Iran 15
JM - Giamaica 15
CL - Cile 13
DZ - Algeria 13
JO - Giordania 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
PE - Perù 12
PY - Paraguay 12
KE - Kenya 11
MY - Malesia 11
NP - Nepal 11
TN - Tunisia 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
IL - Israele 10
PS - Palestinian Territory 10
BO - Bolivia 9
IE - Irlanda 9
SK - Slovacchia (Repubblica Slovacca) 9
AZ - Azerbaigian 8
DK - Danimarca 8
EG - Egitto 8
HN - Honduras 8
KZ - Kazakistan 7
LT - Lituania 7
GR - Grecia 6
KG - Kirghizistan 6
LB - Libano 6
NI - Nicaragua 6
OM - Oman 6
BY - Bielorussia 5
CR - Costa Rica 5
EE - Estonia 5
MD - Moldavia 5
AO - Angola 4
BJ - Benin 4
ET - Etiopia 4
HR - Croazia 4
LU - Lussemburgo 4
PT - Portogallo 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
LK - Sri Lanka 3
MK - Macedonia 3
PR - Porto Rico 3
RO - Romania 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
Totale 29.814
Salva come PNG Salva come JPEG
Città #
Ashburn 1.494
Woodbridge 1.291
Singapore 1.285
Hong Kong 970
Fairfield 967
Ann Arbor 882
Houston 849
San Jose 789
Chandler 788
Santa Clara 708
Dallas 656
Serra 496
Milan 460
Sofia 441
Beijing 419
Shanghai 397
Seattle 385
Wilmington 353
Cambridge 319
New York 294
Council Bluffs 246
Ottawa 243
Boardman 233
Los Angeles 200
Hefei 198
Princeton 187
Jacksonville 177
Lawrence 172
Ho Chi Minh City 157
Lauterbourg 154
Izmir 148
Seoul 144
Medford 134
Vienna 129
Abidjan 127
Nanjing 127
Tokyo 127
Frankfurt am Main 120
Helsinki 119
Pisa 118
Chicago 117
Hanoi 117
Des Moines 109
London 104
Rome 96
Florence 94
Dong Ket 81
Munich 81
Buffalo 79
Istanbul 74
Redondo Beach 69
São Paulo 69
Orem 67
Warsaw 65
Dearborn 60
San Diego 55
Nanchang 48
The Dalles 48
Dakar 47
Redwood City 41
Boulder 40
Grafing 39
Marseille 38
Lucca 37
Atlanta 35
Da Nang 34
Washington 34
Columbus 33
Bern 32
Livorno 30
Amsterdam 29
Fuzhou 27
Guangzhou 27
Kunming 27
Brussels 26
Changsha 26
Pune 26
Rio de Janeiro 26
Shenyang 26
Tianjin 26
Gif-sur-Yvette 25
Hebei 25
Jüchen 25
Naples 25
Toronto 25
Hangzhou 24
Zurich 24
Chennai 23
Norwalk 23
Phoenix 23
Salt Lake City 23
Brooklyn 22
Jiaxing 22
Nuremberg 22
Ogden 22
Turku 22
Johannesburg 21
Lancaster 21
Bremen 18
Lagos 18
Totale 20.095
Salva come PNG Salva come JPEG
Nome #
Metformin conjugates and therapeutic use thereof 390
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 358
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 308
Rimedi fitoterapici per la sindrome dell’ovaio policistico. Review di clinical trials 307
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 290
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 284
Beneficial Effects of Eruca sativa Defatted Seed Meal on Visceral Pain and Intestinal Damage Resulting from Colitis in Rats 277
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 268
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 260
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 252
Antioxidant and Antisenescence Effects of Bergamot Juice 247
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 243
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 240
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 236
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 236
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 229
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 229
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 225
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 225
Emerging role of the cardiac lipidome in the progression of heart failure. 224
Glucoerucin, Glucosinolate From Brassicaceae Vegetables, Improves the Metabolic Profile in a Murine Model of Diet-Induced Obesity 223
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 221
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 217
Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection 217
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 216
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 208
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 207
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 199
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 197
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 194
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 194
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 189
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 188
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 187
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 186
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 186
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 186
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 185
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 183
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 182
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 180
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 180
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 180
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 179
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 179
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 175
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 175
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 175
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 174
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 173
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 173
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 173
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 173
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 173
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 172
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 171
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 170
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 169
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 168
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 167
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 166
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 163
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 160
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 160
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 159
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 153
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 153
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 152
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 151
APRIKALIM ABOLISHES THE QT INTERVAL PROLONGATION THIORIDAZINE-INDUCED BY THE ACTIVATION OF SARCOPLASMIC KATP CHANNELS 149
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 149
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 149
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 149
VASORELAXANT EFFECTS OF THE CHLOROFORMIC CRUDE EXTRACT OF BUPLEURUM FRUTICOSUM L. (UMBELLIFERAE) ROOTS ON RAT THORACIC AORTA 149
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 149
Vasodilator activity of crude methanolic extract of Gentiana Kokiana Perr Et Song (Gentianaceae) 148
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 148
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 148
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 147
Evaluation of the NO-releasing properties of NO-donor linkers 147
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 146
IDENTIFICATION OF "TOXICOPHORIC" FEATURES FOR PREDICTING DRUG-INDUCED QT INTERVAL PROLONGATION 145
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 145
Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection 145
An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate 144
EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL 143
QT PROLONGATION IN ANAESTHETIZED GUINEA-PIGS: AN EXPERIMENTAL APPROACH FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG CANDIDATES 143
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 143
ATTIVATORI DEI CANALI KATP A STRUTTURA 1,4-BENZOTIAZINICA: MODIFICAZIONI IN C-2 E C-6 141
CARDIOVASCULAR EFFECTS OF A NEW NO-RELEASING COXIB DERIVATIVE 140
Luteolin-Induced Activation of Mitochondrial BKCa Channels: Undisclosed Mechanism of Cytoprotection 139
Theoretical Models for Classification as Cardioprotective Agents of Mitochondrial-KATP Channel Openers (mito-KCOs) Possessing the 4-Spiro-substituted Benzopyranic Structure 139
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 139
Efficacy of isothiocyanate-based compounds on different forms of persistent pain 138
Supplementation of Enriched Polyunsaturated Fatty Acids and CLA Cheese on High Fat Diet: Effects on Lipid Metabolism and Fat Profile 138
The Efficacy of Camelina sativa Defatted Seed Meal against Colitis-Induced Persistent Visceral Hypersensitivity: The Relevance of PPAR α Receptor Activation in Pain Relief 137
Totale 18.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.920 0 163 61 77 340 302 56 108 75 55 146 537
2022/20232.752 315 367 183 226 312 371 28 171 551 15 131 82
2023/20241.915 187 235 217 113 256 397 69 61 27 45 73 235
2024/20255.983 61 232 60 340 541 679 486 323 541 830 688 1.202
2025/20267.306 367 911 761 526 695 701 1.288 352 521 695 229 260
2026/20271.284 419 865 0 0 0 0 0 0 0 0 0 0
Totale 30.454